Hemodialysis Machine Market Business Strategy And Forecast Report 2022


The global hemodialysis machine market is expected to witness significant growth over the forecast period owing to rising demand from end-user industries including pharmaceutical, personal healthcare, and medical device. Furthermore, growing prevalence of cardiovascular diseases including coronary artery disease, hypertension, and cardiac aneurysms is anticipated to drive the market growth over the next eight years.

 In addition, the growing adoption of hemodialysis machine for diabetes, and end-stage renal diseases is further projected to propel the sector demand over the forecast period. The market is projected to witness proliferated demand over the next eight years owing to increasing application in curing coronary artery disease, rising need to diagnose kidney failure and growing utilization in high blood sugar patients have age-related issues. However, high initial setup cost coupled with rising fluctuation in the raw material prices has enabled the market to witness hindered growth over the next eight years.

The market is segmented by product into centre-use hemodialysis machines, home-use hemodialysis machines, and others. This centre-use hemodialysis machine segment was accounted for a major market share in 2015 and it is projected to witness similar trend by 2024 owing to growing applications from independent dialysis centres and hospitals. On the other hand, home-use hemodialysis machine is anticipated to report the fastest growth over the next eight years primarily due to increasing demand for home hemodialysis and peritoneal dialysis. The hemodialysis machine market is highly competitive primarily to the presence of several domestic and international suppliers.


Though, the sector has the presence of various new players, who face difficulty in competing with other major companies in terms of functionalities, features, quality, and services. Over the forecast period, the growing new product development activities coupled with increasing adoption of new technologies for achieving operational efficiency has enabled the competition to become more aggressive. On a contrary, few major players through continuous R&D endeavors coupled with growing expertise knowledge in the industry have enabled them to witness competitive edge, thus propelling the overall growth of the sector over the next eight years.

North America and Europe are anticipated to witness major market share over the forecast period owing to the growing number of independent dialysis centres coupled with rising government initiatives to develop better dialysis facilities.  Asia Pacific is anticipated to account for fastest growth over the forecast period primarily due to the increasing ESRD patient population base coupled with growing awareness among end users regarding new developments in the dialysis treatment modalities. India, China, and Japan are anticipated to witness the highest share in the region majorly owing to the rising disposable income coupled with growing foreign investments.  The Middle East & Africa is projected to see significant growth by 2020 mainly owing to increasing urbanization, industrialization, and globalization. The sector has huge potential in this region primarily owing to rising per capita income and foreign investments.

Key players in the market include DaVita Healthcare Partners Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.) and Nipro Corporation (Japan). Few other companies in the hemodialysis industry include Nikkiso Co. Ltd. (Japan), Diaverum Deutschland GmbH (Germany) and NxStage Medical, Inc. (U.S.). The market is highly consolidated having more than 35% market share by major players. The major players generally tend to retain their market share through new product development and through attaining operational efficiency. These players through continuous R&D endeavors focus on building a wide distribution network that supports the overall market to report significant growth over the forecast period. Companies through strategic expansions and mergers & acquisitions have been trying to cater large volume of customers with products that are cost-effective and high quality.




Comments